NCT01996202View on ClinicalTrials.gov

A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions

High Risk Melanoma

Interventions

DRUG

Ipilumimab

RADIATION

Radiation

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER